Navigating the 340B Drug Pricing Program for healthcare providers

Healthy Outcomes: A Baker Tilly Podcast

English - August 08, 2023 05:00 - 31 minutes - 29.1 MB - ★★★★★ - 6 ratings
Business baker tilly emerging technologies healthcare healthcare industry revenue cycle Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Navigating the No Surprises Act: Opportunities and challenges for provider and payer organizations

Next Episode: Exploring home and community-based services: Insights and considerations for healthcare organizations

On this episode of Healthy Outcomes, our host Mark Ross interviews Sherri Faber, president and CEO of 340B Compliance Partners. Together, they discuss the 340B Drug Pricing Program (340B Program), a federal government program created in 1992 that requires pharmaceutical manufacturers to provide outpatient pharmaceuticals to eligible healthcare providers and covered entities at discounted prices.

Twitter @bakertillyusFacebook @BakerTillyUSInstagram @bakertillyus

Presented by Baker Tilly
https://www.bakertilly.com/

Twitter Mentions

@bakertillyus